Mike Damore

Mike Damore

Company: Pfizer

Job title: Director & Lead - Translational Oncology


Panel Discussion: How Do Cell-Based vs Antibody-Based Anti-BCMA Therapies Compare? 10:00 am

Navigating the current treatment landscape of multiple myeloma Bispecifics vs ADCs: Looking at PFS data? Can you compare cell-based vs antibody-based, based on combination rationale? Response, Efficacy, PFS, OS? Discussing BCMA’s potential and limitations; can we become curative? Gathering early clinical information to form robust translational outcomes Discussing the effect of extramedullary disease: should we…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.